Application Notes

Cellastim S – Reconstitution Application Note

rHSA Reconstitution Video Protocol

Blog

Recombinant Virus Platforms are Out in Front in the Race to Develop Vaccines Against SARS-CoV-2 and COVID-19 Disease

The Emergence of Serum-Free Cell Culture Media – Blood-Free Chemically Defined Components

Journal Articles (DOI Links)

Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes

Posters

Cellastim S – Optimizing Antibody Production in Animal-Free Media with the Supplementation of Recombinant Human Albumin

Product Brochures

2021 Product Catalog

Product Specifications

Cellastim S – Product Specifications

SDS

Cellastim S – Safety Data Sheet

Use Guidelines

Cellastim S – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Cellastim S – Recombinant Human Serum Albumin in the Generation of Functional Cardiomyocytes from Pluripotent Stem Cells

Emergence of Blood-Free Recombinant Human Albumin

Optimization of Albumin Inclusion in Cell Culture Media – Fatty Acid Profiles